Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aphria Inc (APHA.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,413,182
  • Shares Outstanding, K 250,233
  • Annual Sales, $ 36,917 K
  • Annual Income, $ 29,448 K
  • 60-Month Beta 3.95
  • Price/Sales 46.97
  • Price/Cash Flow N/A
  • Price/Book 1.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/19
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -162.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.29 +10.41%
on 03/08/19
14.21 -4.50%
on 03/04/19
+0.89 (+7.02%)
since 02/15/19
3-Month
6.16 +120.29%
on 12/24/18
14.37 -5.57%
on 02/04/19
+5.68 (+71.99%)
since 12/18/18
52-Week
4.76 +185.08%
on 12/05/18
22.00 -38.32%
on 09/12/18
-1.17 (-7.94%)
since 03/16/18

Most Recent Stories

More News
Growing Concern Over Chronic Pain Prods Cannabis Market's Growth Ahead

Chronic pain is among one of the most common medical conditions globally. More than 1.5 billion people suffer from the effects of chronic pain and it is the number one cause of long-term disability in...

KSHB : 5.6775 (-0.04%)
APHA : 10.05 (+4.69%)
VFF : 15.95 (+11.46%)
VFF.TO : 21.41 (+9.79%)
VLLFF : 2.4000 (unch)
MLCPF : 2.5871 (+1.70%)
TRST.TO : 12.59 (+5.89%)
APHA.TO : 13.50 (+5.30%)
LABS.VN : 3.450 (+2.07%)
CTST : 9.45 (+6.42%)
How the FDA Plans to Deal With Hemp Now That It's Legal

The Food and Drug Administration (FDA) is considering what it terms "potential regulatory pathways" for the interstate commerce of hemp and cannabis compounds in foods and beverages. This follows the renewal...

WEED.TO : 60.76 (-0.18%)
MMEN.CN : 4.040 (+3.86%)
APHA : 10.05 (+4.69%)
BOSQF : 0.5372 (+0.90%)
APHA.TO : 13.50 (+5.30%)
BOSS.CN : 0.730 (+4.29%)
CGC : 45.44 (-0.98%)
MMNFF : 3.0285 (+4.07%)
CBD Market Segments That Experts are Projecting to Rise

While many have heard or read the bombshell report by the Brightfield Report, that stated: "CBD is growing faster than cannabis in the U.S. and will soon be a $22 billion industry (by 2022). It's been...

TGIF.CN : 0.540 (unch)
APHA : 10.05 (+4.69%)
TGIFF : 0.4020 (-1.95%)
MDGS : 2.88 (-0.35%)
OGRMF : 6.9000 (+2.07%)
OGI.VN : 9.170 (+1.44%)
BOSQF : 0.5372 (+0.90%)
APHA.TO : 13.50 (+5.30%)
BOSS.CN : 0.730 (+4.29%)
Aphria Receives Health Canada License Amendment, Approving Fully Expanded Production at Aphria One

Annual cannabis production capacity at Aphria One increases to 110,000 kg and 115,000 kgs for all licensed facilities

APHA : 10.05 (+4.69%)
APHA.TO : 13.50 (+5.30%)
Aphria Receives Health Canada License Amendment, Approving Fully Expanded Production at Aphria One

Annual cannabis production capacity at Aphria One increases to 110,000 kg and 115,000 kgs for all licensed facilities

APHA : 10.05 (+4.69%)
APHA.TO : 13.50 (+5.30%)
Cannabis Companies Pursuing Growth Set Sights on Latina America

The Latin America region has become highly sought after for cannabis businesses due to the opportunities it represents. Around the globe, many cannabis businesses have moved to establish operations in...

CRON : 21.36 (+1.71%)
PHCEF : 8.1095 (+2.49%)
APHA : 10.05 (+4.69%)
BBRRF : 0.4399 (+26.88%)
CRON.TO : 28.59 (+1.67%)
BBM.CN : 0.570 (+23.91%)
PCLO.VN : 10.820 (+2.85%)
KHRN.VN : 3.930 (+6.22%)
APHA.TO : 13.50 (+5.30%)
North American Hemp-CBD Imports and Exports Projected to Jump

The recent reports that projected the CBD markets will hit $22 billion by 2022 also predict that the world CBD markets could outpace marijuana… or recreational cannabis. This is not only good news for...

CROP.CN : 0.320 (+3.23%)
NXTTF : 0.5710 (-1.64%)
CRXPF : 0.2400 (-0.70%)
OGRMF : 6.9000 (+2.07%)
APHA.TO : 13.50 (+5.30%)
OGI.VN : 9.170 (+1.44%)
TGOD.TO : 5.00 (+9.65%)
APHA : 10.05 (+4.69%)
N.VN : 0.760 (-2.56%)
TGODF : 3.7500 (+9.97%)
Aphria signs worldwide license agreement with Manna Molecular Science to develop state-of-the-art cannabis transdermal patches

LEAMINGTON, ON and WORCESTER, MA , Feb. 26, 2019 /PRNewswire/ - Aphria Inc. (" Aphria " or the " Company ") ( TSX: APHA   and NYSE: APHA ) today announced...

APHA : 10.05 (+4.69%)
APHA.TO : 13.50 (+5.30%)
Aphria signs worldwide license agreement with Manna Molecular Science to develop state-of-the-art cannabis transdermal patches

Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced a worldwide license agreement with Manna Molecular Science, LLC ("Manna"), producers of state-of-the-art cannabis transdermal...

APHA : 10.05 (+4.69%)
APHA.TO : 13.50 (+5.30%)
4 Companies Shaping the Cannabis Retail Market

The cannabis retail market remains one of marijuana's biggest unknowns. Companies have been working on different approaches when it comes to developing stores or products that will appeal to consumers....

WSLFF : 2.2500 (-0.71%)
ACB.TO : 13.17 (+2.65%)
ACB : 9.80 (+1.98%)
APHA : 10.05 (+4.69%)
FONE.CN : 2.480 (+7.36%)
WDDMF : 1.5100 (-0.66%)
WMD.VN : 2.030 (-0.98%)
WL.VN : 3.000 (-0.33%)
FAF.VN : 1.400 (-1.41%)
APHA.TO : 13.50 (+5.30%)
CANA.CN : 0.285 (-1.72%)
FLOOF : 1.8400 (+8.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 13.06
1st Resistance Point 12.94
Last Price 13.53
1st Support Level 12.60
2nd Support Level 12.38

See More

52-Week High 22.00
Fibonacci 61.8% 15.41
Last Price 13.53
Fibonacci 50% 13.38
Fibonacci 38.2% 11.35
52-Week Low 4.76

See More

Business Summary

Aphria Inc and its subsidiaries produce and sell medical marijuana. Its products include Capsules, Oral solutions, and Vaporizers. The company's operations are based in Leamington, Ontario. It is focused on producing and selling medical marijuana and its derivatives through retail sales and wholesale...

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar